ArticleCerebellum (London, England)2021

Antisense Oligonucleotide Therapy Targeted Against ATXN3 Improves Potassium Channel-Mediated Purkinje Neuron Dysfunction in Spinocerebellar Ataxia Type 3.

David D Bushart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.